Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine

Life Sciences

Volumn 82, Issue 7-8, 2008, Pages 413-418

  Gugliucci, Alejandro ^a  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Coagulation; Oxidative stress; Plasmin; Thiols; Thrombosis

Indexed keywords

ACROLEIN; AMINOGUANIDINE; ANTITHROMBIN; CARNOSINE; CYSTEINE; HOMOCYSTEINE THIOLACTONE; PLASMINOGEN;

ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CATALYSIS; ELECTROPHORESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; POLYMERIZATION;

ACROLEIN; ANTITHROMBINS; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HOMOCYSTEINE; HUMANS; PLASMINOGEN; TIME FACTORS;

EID: 39149108124     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.11.023     Document Type: Article

References (35)

1. Arai H., Uchida K., and Nakamura K. Effect of ascorbate on acrolein modification of very low density lipoprotein and uptake of oxidized apolipoprotein e by hepatocytes. Bioscience Biotechnology Biochemistry 69 (2005) 1760-1762
2. Baruah D.B., Dash R.N., Chaudhari M.R., and Kadam S.S. Plasminogen activators: a comparison. Vascular Pharmacology 44 (2006) 1-9
3. Bick R.L. Hypercoagulability and thrombosis. Medical Clinics of North America 78 (1994) 635-665
4. Blomback M., Blomback B., Olsson P., and Svendsen L. The assay of antithrombin using a synthetic chromogenic substrate for thrombin. Thrombosis Research 5 (1974) 621-632
5. Breuille D., Bechereau F., Buffiere C., Denis P., Pouyet C., and Obled C. Beneficial effect of amino acid supplementation, especially cysteine, on body nitrogen economy in septic rats. Clinical Nutrition 25 (2006) 634-642
6. Calingasan N.Y., Uchida K., and Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. Journal of Neurochemistry 72 (1999) 751-756
7. Childs A., Jacobs C., Kaminski T., Halliwell B., and Leeuwenburgh C. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radicals in Biology and Medicine 31 (2001) 745-753
8. Droge W. Oxidative stress and ageing: is ageing a cysteine deficiency syndrome?. Philosophical Transactions of the Royal Society of London. Series B, Biological Science 360 (2005) 2355-2372
9. Frank R.D., Holscher T., Schabbauer G., Tencati M., Pawlinski R., Weitz J.I., and Mackman N. A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury. Thrombosis and Haemostasis 96 (2006) 802-806
10. Friberger P., Axelsson G., and Korsan-Bengtsen K. Proceedings: determination of plasminogen by means of a chromogenic peptide substrate. Thrombosis Diathesis Haemorrhage 34 (1975) 321-327
11. Fujioka K., and Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environmental Toxicology 21 (2006) 47-54
12. Gugliucci A., Lunceford N., Kinugasa E., Ogata H., Schulze J., and Kimura S. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clinica Chimica Acta 384 (2007) 105-112
13. Gugliucci A., Tsuji M., Kinugasa E., Ogata H., Ikeda H., Shikama Y., and Kimura S. High free serum acrolein levels in bacterial infection and other disease states associated with oxidative stress:a potential biomarker?. Clinical Chemistry and Laboratory Medicine 45 (2007) 1559-1560
14. Gugliucci A., and Menini T. The polyamines spermine and spermidine protect proteins from structural and functional damage by AGE precursors: a new role for old molecules?. Life Sciences 72 (2003) 2603-2616
15. Harpel P.C., Zhang X., and Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. Journal of Nutrition 126 (1996) 1285S-1289S
16. Hathuc C., Hermo R., Schulze J., and Gugliucci A. Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity. Clinical Chemistry and Laboratory Medicine 44 (2006) 213-219
17. Jaimes E.A., DeMaster E.G., Tian R.X., and Raiji L. Stable compounds of cigarette smoke induce endothelial superoxide anioun production via NADPH oxidase activation. Artheriosclerosis Thrombosis and Vascular Biology 24 (2004) 1031-1036
18. Jakubowski H. Pathophysiological consequences of homocysteine excess. Journal of Nutrition 136 (2006) 1741S-1749S
19. Johnson D.J., Langdown J., Li W., Luis S.A., Baglin T.P., and Huntington J.A. Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation. Journal of Biological Chemistry 281 (2006) 35478-35486
20. Kehrer J.P., and Biswal S.S. The molecular effects of acrolein. Toxicological Sciences 57 (2000) 6-15
21. Kelly G.S. Clinical applications of N-acetylcysteine. Alternative Medicine Reviews 3 (1998) 114-127
22. Leone A. Smoking, haemostatic factors, and cardiovascular risk. Current Pharmacology Design 13 (2007) 1661-1667
23. Marchetti G., Lodola E., Licciardello L., and Colombo A. Use of N-acetylcysteine in the management of coronary artery diseases. Cardiologia 44 (1999) 633-637
24. Mercado C., and Jaimes E.A. Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insisghts. Current Hypertension Reports 9 (2007) 66-72
25. Nieuwdorp M., Stroes E.S., Meijers J.C., and Buller H. Hypercoagulability in the metabolic syndrome. Current Opinion in Pharmacology 5 (2005) 155-159
26. Sakurai T., Boissel J.P., and Bunn H.F. Non-enzymatic glycation of antithrombin III in vitro. Biochimica et Biophysica Acta 964 (1988) 340-347
27. Sauls D.L., Lockhart E., Warren M.E., Lenkowski A., Wilhelm S.E., and Hoffman M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 45 (2006) 2480-2487
28. Shao B., Fu X., McDonald T.O., Green P.S., Uchida K., O'Brien K.D., Oram J.F., and Heinecke J.W. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. Journal of Biological Chemistry 280 (2005) 36386-36396
29. Shao B., O'Brien K.D., McDonald T.O., Fu X., Oram J.F., Uchida K., and Heinecke J.W. Acrolein modifies apolipoprotein A-I in the human artery wall 1043 (2005), Annals of the New York Academy of Sciences 396-403
30. Tamamizu-Kato S., Wong J.Y., Jairam V., Uchida K., Raussens V., Kato H., Ruysschaert J.M., and Narayanaswami V. Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E. Biochemistry 46 (2007) 8392-8400
31. Tanel A., and Averill-Bates D.A. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. Journal of Pharmacology and Experimental Therapeutics 321 (2007) 73-83
32. Thomas R.H. Hypercoagulability syndromes. Archives of Internal Medicine 161 (2001) 2433-2439
33. Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N., and Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. Journal of Biological Chemistry 273 (1998) 16058-16066
34. Undas A., Brozek J., Jankowski M., Siudak Z., Szczeklik A., and Jakubowski H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arteriosclerosis Thrombosis and Vascular Biology 26 (2006) 1397-1404
35. Yang X., Gao Y., Zhou J., Zhen Y., Yang Y., Wang J., Song L., Liu Y., Xu H., Chen Z., and Hui R. Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease. Clinica Chimica Acta 364 (2006) 230-234